Provided By GlobeNewswire
Last update: Mar 28, 2024
GUANGZHOU, China, March 28, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months and the year ended December 31, 2023.
NASDAQ:BNR (2/21/2025, 8:03:58 PM)
7.15
+0.06 (+0.85%)
Find more stocks in the Stock Screener